Yes, SIGA Technologies is an American commercial-stage pharmaceutical enterprise legally incorporated and headquartered in the United States, with its primary corporate administrative offices located in New York City, New York. The company focuses primarily on health security, biodefense countermeasures, and antiviral drug development to support United States federal agencies and allied global health organizations.